VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
DBD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
DBDDiebold Nixdorf, Incorporated
$58.27$2.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksDBDFinancials

Diebold Nixdorf, Incorporated (DBD) Income Statement

30Y historyFree accessUpdated daily

Revenue rose from $841.1M in 2025Q1 to roughly $1.1B in 2025Q4 before easing to $994.3M, yet operating margin compressed to 3.9% in 2026Q3 from 11.6% in 2025Q4, indicating weak operating leverage.

Income StatementBalance SheetCash FlowRatios

DBD Income Statement

Annual statement

DBD Income Statement

Diebold Nixdorf, Incorporated (DBD) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue3.92B3.81B3.75B3.76B3.46B3.91B3.9B4.41B4.58B4.61B3.32B2.42B3.05B2.86B2.99B2.84B2.82B2.72B3.17B2.96B2.91B2.59B2.38B2.11B1.94B1.76B1.74B1.26B1.19B1.23B1.03B
Revenue Growth %6.25%1.46%-0.25%8.66%-11.38%0.07%-11.48%-3.72%-0.67%38.99%37.08%-20.71%6.77%-4.49%5.5%0.43%3.88%-14.25%6.92%2.02%12.34%8.66%12.86%8.74%10.22%0.96%38.47%6.2%-3.36%19.09%19.32%
Cost of Goods Sold2.91B2.8B2.83B2.88B2.7B2.86B2.87B3.33B3.69B3.58B2.57B1.76B2.27B2.22B2.26B2.1B2.1B2.07B2.38B2.28B2.2B1.96B1.7B1.48B1.35B1.24B1.15B767.7M744M768.4M639.3M
COGS % of Revenue-73.63%75.47%76.7%78.12%73.28%73.48%75.58%80.54%77.68%77.47%72.86%74.46%77.59%75.39%74.05%74.52%76.09%74.93%76.93%75.55%75.82%71.51%70.27%69.35%70.23%65.87%60.97%62.75%62.63%62.06%
Gross Profit1.01B1B920M876.2M757.3M1.04B1.03B1.08B890.9M1.03B747.2M656.5M779.35M640.36M736.15M735.93M719.57M650M794.62M683.85M710.52M625.48M678.38M627.14M594.64M524.07M595.06M491.5M441.7M458.5M390.9M
Gross Margin %25.8%26.37%24.53%23.3%21.88%26.72%26.52%24.42%19.46%22.32%22.53%27.14%25.54%22.41%24.61%25.95%25.48%23.91%25.07%23.07%24.45%24.18%28.49%29.73%30.65%29.77%34.13%39.03%37.25%37.37%37.94%
Gross Profit Growth %-9.07%5%15.7%-27.42%0.81%-3.85%20.82%-13.42%37.71%13.82%-15.76%21.71%-13.01%0.03%2.27%10.7%-18.2%16.2%-3.75%13.6%-7.8%8.17%5.47%13.47%-11.93%21.07%11.27%-3.66%17.29%20.69%
Operating Expenses730.1M668.8M737.9M789.3M969M906.3M1.01B841.4M1.04B893.6M686.7M522.1M609.17M689.01M595.66M577.37M545.52M496.91M618.34M584.49M534.86M464.21M401.41M364.29M353.47M385.16M366.1M306.6M274.3M274.7M250.6M
OpEx % of Revenue-17.57%19.67%20.99%28%23.21%25.91%19.09%22.78%19.39%20.71%21.58%19.97%24.11%19.91%20.36%19.32%18.28%19.51%19.71%18.4%17.94%16.86%17.27%18.22%21.88%21%24.35%23.13%22.39%24.33%
Selling, General & Admin642.8M585M643.6M0741.6M775.6M858.6M697.3M885.6M737M581.6M435.8M515.55M596.69M509.78M499.26M471.29M424.88M534.49M470.62M463.86M403.8M341.39M303.84M289.58M325.54M274.51M221.4M194.5M191.8M217.6M
SG&A % of Revenue-15.37%17.16%-21.43%19.86%22%15.82%19.34%15.99%17.54%18.01%16.9%20.88%17.04%17.61%16.69%15.63%16.86%15.87%15.96%15.61%14.34%14.4%14.93%18.49%15.74%17.58%16.4%15.63%21.12%
Research & Development83.4M83.8M93.6M110.9M120.7M126.3M133.4M144.1M157.4M156.6M105.1M86.3M93.62M92.31M85.88M78.11M74.22M72.03M79.07M73.95M71M60.41M60.02M60.45M63.89M59.61M55.69M50.5M54.2M54.4M0
R&D % of Revenue-2.2%2.5%2.95%3.49%3.23%3.42%3.27%3.44%3.4%3.17%3.57%3.07%3.23%2.87%2.75%2.63%2.65%2.49%2.49%2.44%2.34%2.52%2.87%3.29%3.39%3.19%4.01%4.57%4.43%-
Other Operating Expenses-600K0700K678.4M106.7M4.4M19M0-4M8.8M3.5M3.7M-1.65M-1.55M00-1.66M7K403K39.93M00000035.9M34.7M25.6M28.5M33M
Operating Income281.6M334.6M182.1M86.9M-211.7M137.1M24M235M-362.9M135.4M60.5M134.4M180.95M-118.26M124.71M155.59M-1.8M150.59M176.28M99.36M175.66M161.27M276.97M262.85M241.17M138.91M228.96M184.9M167.4M183.8M140.3M
Operating Margin %7.18%8.79%4.85%2.31%-6.12%3.51%0.61%5.33%-7.93%2.94%1.82%5.56%5.93%-4.14%4.17%5.49%-0.06%5.54%5.56%3.35%6.04%6.23%11.63%12.46%12.43%7.89%13.13%14.68%14.12%14.98%13.62%
Operating Income Growth %-83.75%109.55%141.05%-254.41%471.25%-89.79%164.76%-368.02%123.8%-54.99%-25.72%253.01%-194.83%-19.85%8734.52%-101.2%-14.57%77.42%-43.44%8.92%-41.77%5.37%8.99%73.62%-39.33%23.83%10.45%-8.92%31%31.37%
EBITDA407.2M462.1M314.4M223.2M-85.7M286.2M204.4M461.1M-115.1M387.6M195.3M198.4M255.02M-35.67M203.36M235.45M77.45M228.28M256.75M162.74M245.47M237.51M351.96M327.15M302.46M184.36M264.86M219.6M193M212.3M173.3M
EBITDA Margin %10.38%12.14%8.38%5.94%-2.48%7.33%5.24%10.46%-2.51%8.41%5.89%8.2%8.36%-1.25%6.8%8.3%2.74%8.4%8.1%5.49%8.45%9.18%14.78%15.51%15.59%10.47%15.19%17.44%16.28%17.3%16.82%
EBITDA Growth %9.91%46.98%40.86%360.44%-129.94%40.02%-55.67%500.61%-129.7%98.46%-1.56%-22.2%815.02%-117.54%-13.63%204%-66.07%-11.09%57.77%-33.7%3.35%-32.52%7.58%8.16%64.06%-30.39%20.61%13.78%-9.09%22.5%27.15%
D&A (Non-Cash Add-back)125.6M127.5M132.3M136.3M126M149.1M180.4M226.1M247.8M252.2M134.8M64M74.07M82.59M78.64M79.86M79.25M77.69M80.47M63.38M69.81M76.24M74.98M64.3M61.3M45.45M35.9M34.7M25.6M28.5M33M
EBIT216.9M207.3M202.6M148.6M-239.4M144.6M-2.7M-32.8M-323.4M-78.5M-141.8M134.4M196.81M-112.6M141.22M193.39M35.49M159.26M201.68M99.36M182.23M182.75M273.48M251.79M241.17M138.91M228.96M184.9M167.4M183.9M140.3M
Net Interest Income-81.3M-76.8M-143M-233.2M-189.2M-189.2M-266.6M-193.6M-146.2M-97M-79.9M-6.5M3.1M-29.2M-30.33M-34.46M-37.89M-35.45M-45.37M000000000000
Interest Income13.4M8.9M12.3M13M10M6.1M6.8M9.3M8.7M20.3M21.5M26M34.5M000000000000000000
Interest Expense94.7M85.7M155.3M246.2M199.2M195.3M273.4M202.9M154.9M117.3M101.4M32.5M31.4M29.23M30.33M34.46M37.89M35.45M45.25M000000000000
Other Income/Expense-156.4M-213M-132.3M1.37B-224.7M-187.5M-292.8M-462.9M-152.7M-98.4M-68.5M-12.8M-10.36M20.49M-7.29M8.8M-595K-26.79M-19.96M-24.02M-18.19M-352K-313K5.23M-22.62M-39.07M-24.6M16.5M-47.6M1.8M6.2M
Pretax Income125.2M121.6M49.8M1.45B-436.4M-50.4M-268.8M-227.9M-515.6M-191.9M-238.3M45.8M170.59M-119.81M117.43M164.39M-2.4M123.81M138.96M75.34M124.45M138.25M268.94M257.02M218.55M99.84M204.36M201.4M119.8M185.6M146.5M
Pretax Margin %3.19%3.2%1.33%38.62%-12.61%-1.29%-6.89%-5.17%-11.26%-4.16%-7.19%1.89%5.59%-4.19%3.93%5.8%-0.08%4.55%4.38%2.54%4.28%5.34%11.3%12.18%11.26%5.67%11.72%15.99%10.1%15.13%14.22%
Income Tax42.4M24.1M64.3M75.7M149.2M27.7M-1M116.7M37.2M28.3M-67.6M-13.7M53.57M56.72M29.91M12.81M14.56M44.48M32.55M35.8M37.9M55.35M84.99M82.25M86.25M32.95M67.44M72.5M43.7M63.1M49.1M
Effective Tax Rate %33.87%19.82%129.12%5.21%-34.19%-54.96%0.37%-51.21%-7.21%-14.75%28.37%-29.91%31.4%-47.34%25.47%7.8%-607.47%35.92%23.42%47.52%30.46%40.03%31.6%32%39.46%33%33%36%36.48%34%33.52%
Net Income76.7M94.6M-16.5M1.38B-581.4M-78.8M-269.1M-341.3M-568.7M-241.5M-178M76.8M114.42M-181.6M78.45M144.81M-20.25M41.61M93.46M39.54M86.55M96.75M183.96M174.78M99.15M66.89M136.92M128.9M76.1M122.5M97.4M
Net Margin %1.96%2.49%-0.44%36.59%-16.8%-2.02%-6.9%-7.74%-12.42%-5.24%-5.37%3.17%3.75%-6.36%2.62%5.11%-0.72%1.53%2.95%1.33%2.98%3.74%7.73%8.28%5.11%3.8%7.85%10.24%6.42%9.98%9.45%
Net Income Growth %51.58%673.33%-101.2%336.69%-637.82%70.72%21.15%39.99%-135.49%-35.67%-331.77%-32.88%163%-331.48%-45.82%815.07%-148.67%-55.48%136.36%-54.31%-10.54%-47.41%5.25%76.27%48.23%-51.14%6.22%69.38%-37.88%25.77%27.82%
Net Income (Continuing)82.8M97.5M-14.5M1.38B-585.6M-78.1M-267.8M-344.6M-528.7M-213.9M-179.3M59.5M107.3M-190.2M87.52M151.58M-16.96M79.33M114.82M47.91M93.14M89.73M181.81M171.27M132.3M66.89M136.92M128.9M76.1M122.5M97.4M
Discontinued Operations0000000000015.9M000523K000011.41M2.23M1.99M00000000
Minority Interest7.9M4.9M8.4M15.4M9.8M8.1M14.6M44.9M157.2M528.9M477.5M23.1M23.29M24.05M35.35M31.27M28.66M25.65M17.66M13.76M27.35M21.55M25.53M20.35M14.32M9.38M5.26M4.4M3.7M16.9M13.1M
EPS (Diluted)2.222.54-0.4421.38-7.44-1.00-3.47-4.51-7.48-3.20-2.581.121.76-2.851.232.24-0.310.621.410.591.551.432.532.371.370.931.921.851.101.761.42
EPS Growth %56.2%677.27%-102.06%387.37%-644%71.18%23.06%39.71%-133.75%-24.03%-330.36%-36.36%161.75%-331.71%-45.09%822.58%-150%-56.03%138.98%-61.94%8.39%-43.48%6.75%72.99%47.31%-51.56%3.78%68.18%-37.5%23.94%-14.97%
EPS (Basic)-2.57-0.4421.38-7.44-1.00-3.47-4.51-7.48-3.20-2.581.141.77-2.851.242.25-0.310.631.410.601.571.452.552.391.380.941.921.861.101.781.42
Diluted Shares Outstanding34.6M37.2M37.6M64.36M79M78.3M77.6M76.7M76M75.5M69.1M65.6M65.15M63.66M63.91M64.79M65.91M66.87M66.49M66.67M67.25M71.34M72.53M72.92M72.3M71.78M71.48M69.56M69.31M69.6M68.8M
Basic Shares Outstanding33.7M36.8M37.6M64.36M79M78.3M77.6M76.7M76M75.5M69.1M64.9M64.53M63.66M63.06M64.24M65.91M66.26M66.08M65.84M66.67M70.58M72M72.42M71.98M71.52M71.3M69.36M68.96M68.82M68.8M
Dividend Payout Ratio-----------98.44%65.5%-92.83%50.34%-166.91%71.22%157.92%66.33%59.71%28.94%28.17%47.93%68.43%32.33%32.35%50.72%28.16%32.03%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Thin net margins and volatile earnings

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Growth Modest Despite Volatility

Based on reported quarterly figures, DBD's revenue rose from $841.1M in 2025Q1 to roughly $1.1B in 2025Q4 before easing to $994.3M in 2026Q3, suggesting top-line momentum that is real but uneven across periods.

Year-over-year growth has oscillated between negative and low-double-digit readings, which indicates the revenue base is not yet compounding on a steady basis. The reported figures do not isolate volume, pricing, or acquisition contributions, so the durability of the 2025Q4 spike cannot be assessed with confidence. Investors should monitor whether sequential revenue holds near the $930M to $995M range in coming quarters.

Gross Margin Holds Within Narrow Band

As reported in financial statements, DBD's gross margin has stayed between 23.9% and 27.1% across ten quarters, with the peak at 27.1% in 2025Q4 coinciding with the revenue high.

A tight gross margin range suggests limited evidence of pricing power or meaningful mix shift, since the business absorbs cost movements without sustained expansion. The 2025Q4 peak appears tied to a seasonal or volume-driven revenue quarter rather than a structural step-up. Margin stability is a positive for predictability but leaves little cushion if input or labor costs rise.

Operating Margin Fragile Beneath Gross Profit

Based on EDBL-style reporting conventions applied here, DBD's operating margin ranged from 3.9% to 11.6%, and the 2026Q3 compression to 3.9% against a 24.9% gross margin points to weak operating leverage.

Operating income swings far more than gross profit, implying that SG&A, which runs near $150M to $170M per quarter, absorbs most incremental gross profit. The reported SG&A line also shows a zero entry in 2025Q3 and 2024Q4, which is treated here as data unavailable rather than evidence of cost reclassification. Operating leverage therefore appears limited, and margin recovery depends on overhead discipline rather than revenue alone.

Net Income Swings Outpace Operating Trend

According to recent SEC filings as summarized here, DBD's net income moved between a loss of $22.4M and a gain of $49.6M, with EPS swinging from -0.60 to 1.37, a dispersion far wider than operating income.

The gap between operating income and net income suggests material non-operating items, tax effects, or discrete charges influencing reported earnings, though the provided data does not itemize them. Stock-based compensation is modest at roughly $2M to $4M per quarter, so it does not explain the volatility. Earnings quality should be treated as uncertain until the drivers of the net-to-operating divergence are identified.

Thin Margins Leave Little Room for Error

Bearish analysis based on reported figures highlights that DBD's net margin has frequently sat below 2%, including 0.6% in 2026Q1 and 0.7% in 2026Q3, leaving earnings highly exposed to small cost or revenue shocks.

A net margin near 1% means modest deterioration in gross profit or overhead could push the company into sustained losses, as already occurred in 2024Q3 and 2025Q1. Peer context shows NCR Atleos with an operating margin near 11%, which, if comparable, would indicate DBD trails on operating efficiency. Investors should monitor whether the 2026 margin compression reflects a durable shift or a temporary cost event.

DBD — Frequently Asked Questions

Quick answers to the most common questions about buying DBD stock.

What was Diebold Nixdorf, Incorporated's (DBD) revenue in 2025?

For fiscal year 2025, Diebold Nixdorf, Incorporated (DBD) reported total revenue of $3.81B. This represents a 269.4% increase compared to $1.03B in 1996.

Is Diebold Nixdorf, Incorporated (DBD) profitable?

Diebold Nixdorf, Incorporated (DBD) is profitable, generating $94.6M in net income for the fiscal year ending 2025 with a net profit margin of 2.5%.

What is Diebold Nixdorf, Incorporated's operating profit margin?

Diebold Nixdorf, Incorporated (DBD) reported an operating income of $334.6M, resulting in an operating profit margin of 8.8%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Diebold Nixdorf, Incorporated's gross profit and gross margin?

Diebold Nixdorf, Incorporated (DBD) generated $1.00B in gross profit for the year, representing a gross profit margin of 26.4%. This demonstrates the company's core pricing power and production efficiency.